Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02652 CF PHARMTECH
RT Nominal unchange10.360 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others548,4360.186%547,420531,132402,060299,390
Land & other Lease Assets27,261-1.971%27,80931,16528,38829,071
Intangible Assets154,500-0.249%154,885121,95294,93475,513
Interests in Asso. & JCEs32,500779.091%3,6971,8271,9010
Other Non-current Assets202,17232.749%152,296110,734112,819126,980

964,8698.889%886,107796,810640,102530,954
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories50,86838.620%36,69647,18036,09828,291
Trade Receivables174,8579.720%159,36627,1302,8708,937
Cash & Bank Balances351,274-15.335%414,89781,93770,61274,838
Other Current Assets195,647-29.925%279,197305,969385,463372,198
Assets Held for Sale0--0000

772,646-13.201%890,156462,216495,043484,264
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables22,6846.114%21,37720,58727,20613,117
S-T Debt & Leases104,943127.736%46,08120,8992,7131,264
Other Current Liabilities113,130-10.571%126,503204,122141,546122,808
Liab asso w/ Assets Held for Sale0--0000

240,75724.126%193,961245,608171,465137,189
Net Current Assets531,889-23.601%696,195216,608323,578347,075
Total Assets Less Current Liabilities1,496,758-5.406%1,582,3021,013,418963,680878,029
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases107,3837.946%99,47858,19819,200240
Other Non-current Liabilities47,296226.337%14,49315,93834,45715,863

154,67935.718%113,97174,13653,65716,103
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital411,9780.000%411,978370,780370,780370,780
  Reserves930,101-11.952%1,056,353568,502539,243491,146
  Others0--0000
Shareholders' Funds1,342,079-8.598%1,468,331939,282910,023861,926
Non-controlling Interests0--0000
Others0--0000

1,342,079-8.598%1,468,331939,282910,023861,926
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments------108,710134,366143,051
Contingent Liabilities------000
Remarks:  Real time quote last updated: 14/09/2026 09:11
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -10,506
%Change754.146%
EPS / (LPS)RMB -0.026
NBV Per Share (¥)RMB 3.269
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.